FFR according to minimal residual disease in the BM after treatment. PCR Neg refers to patients achieving a molecular negativity after CHOP (n = 23) or CHOP and rituximab (n = 25). Patients in the PCR Pos curve were all treated with sequential CHOP and rituximab but failed to achieve a molecular remission.